PRHB Pure H2O Bio Technologies Inc New (CE)

Pure H2O Bio-Technologies, Inc. (Pink Sheets:PRHB) announced today it successfully completed Pre-Certification Testing Results for Integrated Hospital Potable Water Disinfection System. Pure H20 Bio-Technologies, Inc. is proud to announce the successful completion of pre-certification testing of an innovative drinking water treatment system. For several months, Clancy Environmental Consultants, Inc. has been testing the efficacy of a water purification system, using tetrasilvertetraoxide (TTO) for killing pathogenic organisms not killed by the traditional water treatment by halogenated compounds such as chlorine, bromine, and fluorine. The primary goal was to achieve disinfection of Cryptosporidium parvum, a protozoan that has caused worldwide concern, including severe diarrhea in most individuals and even deaths for immunocompromised individuals, and which is especially difficult to eradicate. In addition, tests included disinfection of Escherichia coli, an important enteric pathogenic organism. Both of these pathogens enter the water distribution system due to contamination from animal and human feces. The testing was to ensure that a complete integration of disinfectant (i.e., TTO) and the delivery system could achieve the same level of disinfection previously achieved in basic research studies performed in a batch reaction system. Briefly, successful disinfection to exceeding the level of detection of live pathogens was achieved. Chemical analyses performed in parallel with these studies assured us that the appropriate concentrations of TTO were being delivered to the holding tank, where contact with the pathogens was achieved. These results are now sufficient to allow Pure H20 Bio-Technologies, Inc., to take the system through certification, the next step before marketing, manufacturing, and sales. These organisms are not resistant to treatment with the silverTTO which has been tested by Pure H2O Bio-Technologies, Inc. (PRHB) in laboratory level studies and is now being verified with the state-of-the-art patent-pending treatment/delivery system that is underway. The system is also designed to remove chemical contaminants and metals that are present in source water. Certification of this system through EPA's contractor, National Sanitation Foundation (NSF) is expected to be completed within a few short months and has a high likelihood for success. This system will be available to individuals and hospitals as a system delivering "pathogen-free and chemical-free" water. Pure H2O Bio-Technologies, Inc., www.pureh20biotech.com, has been developing a water treatment system designed to kill the pathogenic microbes such as those cited above and to deliver highly purified water at the point-of-entry (POE) and point-of-use (POU), namely for residential, commercial, hospital and medical facilities. "Our potable water disinfection systems, in the near-final and certification testing stages, can provide both disinfection and purification of the contaminated water. On July 31, 2007, the Company was awarded patent #7250111, and has two additional patents pending at this time that are under review with the U.S. Patent and Trademark Office, Washington, D.C.," stated Joseph P. Doxey, President of Pure H2O Bio-Technologies, Inc. About Pure H2O Bio-Technologies, Inc.: Pure H2O Bio-Technologies, Inc.(PRHB) is a publicly held company specializing in the manufacturing, design, and sale of its unique residential, commercial and hospital point-of-use potable water disinfection systems. These systems are specifically designed to work effectively against water-borne pathogens and remove heavy metals and objectionable biomasses. For further technical information, please visit our website at www.pureh20biotech.com. The foregoing press release contains forward-looking statements that can be identified by such terminology as "expects," "potential," "suggests," "may," "intends," or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause the actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. In particular, management's expectations regarding future research, development, and/or commercial results could be affected by, among other things, uncertainties relating to the availability of future financing; unexpected regulatory delays or government regulation generally; the Company's ability to obtain or maintain patent and other proprietary intellectual property protection; and completion in general. Forward-looking statements speak only as to the date they were made. The Company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.